Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: A population-based cohort study

Lancet

Volumn 360, Issue 9337, 2002, Pages 891-894

  Bergfeldt, Kjell ^a   Rydh, Bosse ^a   Granath, Fredrik ^a   Grönberg, Henrik ^a,b   Thalib, Lukman ^a,c   Adami, Hans Olov ^a   Hall, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 0037152091     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11023-3     Document Type: Article

References (21)

1. Harvey E.B., Brinton L.A. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr. 68:1985;99-112.
2. Ewertz M., Mouridsen H.T. Second cancer following cancer of the female breast in Denmark, 1943-80. Natl Cancer Inst Monogr. 68:1985;325-329.
3. Brenner H., Siegle S., Stegmaier C., Ziegler H. Second primary neoplasms following breast cancer in Saarland, Germany, 1968-1987. Eur J Cancer. 10:1993;1410-1414.
4. Volk N., Pompe-Kirn V. Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control. 8:1997;764-770.
5. Suris-Swartz P.J., Schildkraut J.M., Vine M.F., Hertz-Picciotto I. Age at diagnosis and multiple primary cancers of the breast and ovary. Breast Cancer Res Treat. 41:1996;21-29.
6. Ford D., Easton D.F., Bishop D.T., Narod S.A., Goldgar D.E. Risks of cancer in BRCA1-mutation carriers. Lancet. 343:1994;692-695.
7. Frank T.S., Manley S.A., Olopade O.I., et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 16:1998;2417-2425.
8. Loman N., Johannsson O., Kristoffersson U., Olsson H., Borg A. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst. 93:2001;1215-1223.
9. Syrjakoski K., Vahteristo P., Eerola H., et al. Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst. 92:2000;1529-1531.
10. Anglian Breast Cancer Study Group . Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer. 83:2000;1301-1308.
11. Papelard H., de Bock G.H., van Eijk R., et al. Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients. Br J Cancer. 83:2000;719-724.
12. Newman B., Mu H., Butler L.M., Millikan R.C., Moorman P.G., King M.C. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA. 279:1998;915-921.
13. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 343:2000;78-85.
14. Anon. Cancer incidence in Sweden 1998. Stockholm: Centre for epidemiology, 2000.
15. Anon. Causes of death 1997. Stockholm: National Board of Health and Welfare, 2000
16. Breslow N.E., Day N.E. Statistical methods in cancer research. Volume II - The design and analysis of cohort studies. IARC Sci Publ. 82:1987;1-406.
17. Ovarian ablation for early breast cancer (Cochrane Review). Cochrane Database Syst Rev 2000; 3: CD000485.
18. Dees E.C., Davidson N.E. Ovarian ablation as adjuvant therapy for breast cancer. Semin Oncol. 28:2001;322-331.
19. Hensley M.L., Castiel M., Robson M.E. Screening for ovarian cancer: what we know, what we need to know. Oncology (Huntingt). 14:2000;1601-1607.
20. Menon U., Jacobs I.J. Recent developments in ovarian cancer screening. Curr Opin Obstet Gynecol. 12:2000;39-42.
21. Dorum A., Kristensen G.B., Abeler V.M., Trope C.G., Moller P. Early detection of familial ovarian cancer. Eur J Cancer. 32A:1996;1645-1651.